Evaxion（易瓦克）在知名醫學雜誌上發佈了數據，顯示由人工智能設計的個性化癌症生物-疫

快訊 · 06/17 20:44

Evaxion Publishes Data, Showing 67% Objective Response Rate in Metastatic Melanoma for the AI-Designed Personalized Cancer Vaccine Evx-01, in Leading Medical Journal

Evaxion（易瓦克）在知名醫學雜誌上發佈了數據，顯示由人工智能設計的個性化癌症生物-疫苗Evx-01在轉移性黑色素瘤患者中有67%的客觀反應率。